Skip to content

Plasma renin test guided drug treatment algorithm for correcting different subtypes of hypertension in treated but uncontrolled patients

Plasma renin test guided drug treatment algorithm for correcting different subtypes of hypertension in treated but uncontrolled patients: a randomized trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15531697
Enrollment
180
Registered
2012-01-24
Start date
2009-11-02
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, treated but uncontrolled Circulatory System Hypertension secondary to other renal disorders

Interventions

1. RTGT: The antihypertensive drugs were chosen based on the renin test guided therapeutic (RTGT) algorithm. 2. Senior General Cardiologists? Care (SGCC): The antihypertensive drugs were chosen based

Sponsors

Second Hospital of Hebei Medical University (China)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Established hypertensive patients 2. 18 years or older 3. Male or female of any race or ethnicity 4. Have never had anti-hypertensive medication 5. Have had anti-hypertensive medication but not for at least two weeks

Exclusion criteria

Exclusion criteria: 1. Any comorbidities requiring the medications that interferes with blood pressure (BP) levels (e.g. non-steroidal anti-inflammatory drugs with the exception of aspirin) 2. Any contraindications to any types of antihypertensive drug applied in this study (e.g. asthma) 3. Any situations leading to poor adherence to the study protocol (e.g. mental illness or instability in BP levels e.g. cardiovascular neurosis) 4. Home BP 135/85 mmHg 5. History of white-coat hypertension 6. Serum creatinine >2.5 mg/dl

Design outcomes

Primary

MeasureTime frame
Differences in change in BPs between RTGT and SGCC groups with the three hypertension subtypes, respectively, and between the three hypertension subtypes within RTGT group.

Secondary

MeasureTime frame
Differences in change in the antihypertensive drug number between RTGT and SGCC groups with the three hypertension subtypes, respectively, and between the three hypertension subtypes within RTGT group.

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026